Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy.

Ayoub Z, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS, Ng SP, Gunther JR, Khoury JD, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Nastoupil LJ.

Leuk Lymphoma. 2019 Apr 3:1-9. doi: 10.1080/10428194.2019.1597081. [Epub ahead of print]

PMID:
30942648
2.

Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes.

Andraos T, Ayoub Z, Nastoupil L, Pinnix C, Milgrom S, Gunther J, Ng SP, Fowler N, Neelapu S, Samaniego F, Dabaja B.

Clin Lymphoma Myeloma Leuk. 2019 Feb 26. pii: S2152-2650(18)31509-X. doi: 10.1016/j.clml.2019.02.011. [Epub ahead of print]

PMID:
30935940
3.

Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.

Ng SP, Pollard C 3rd, Berends J, Ayoub Z, Kamal M, Garden AS, Bahig H, Cantor SB, Schaefer AJ, Ajayi T, Gunn GB, Frank SJ, Skinner H, Phan J, Morrison WH, Ferrarotto R, Johnson JM, Mohamed ASR, Lai SY, Hessel AC, Sturgis EM, Weber RS, Fuller CD, Rosenthal DI.

Cancer. 2019 Jun 1;125(11):1823-1829. doi: 10.1002/cncr.31983. Epub 2019 Feb 12.

PMID:
30748005
4.

Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma.

Bahig H, Lapointe A, Bedwani S, de Guise J, Lambert L, Filion E, Roberge D, L├ętourneau-Guillon L, Blais D, Ng SP, Nguyen-Tan PF.

Eur J Radiol. 2019 Jan;110:1-6. doi: 10.1016/j.ejrad.2018.11.005. Epub 2018 Nov 5.

PMID:
30599844
5.

Extracting tumour prognostic factors from a diverse electronic record dataset in genito-urinary oncology.

Khor RC, Nguyen A, O'Dwyer J, Kothari G, Sia J, Chang D, Ng SP, Duchesne GM, Foroudi F.

Int J Med Inform. 2019 Jan;121:53-57. doi: 10.1016/j.ijmedinf.2018.10.008. Epub 2018 Oct 23.

PMID:
30545489
6.

Dosimetric advantages of stereotactic radiosurgery as a boost to adjuvant conventional radiotherapy in the setting of adenoid cystic carcinoma of the parotid with skull base invasion.

Phan JL, Pollard C 3rd, Wang H, Ng SP, Sheu T, Ginsberg LE, Hessel AC, Gidley PW, Rosenthal DI, Phan J.

Clin Case Rep. 2018 Sep 23;6(11):2126-2130. doi: 10.1002/ccr3.1788. eCollection 2018 Nov.

7.

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial.

Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS, Rosenthal DI, Gunn GB, Phan J, Cazoulat G, Aristophanous M, McSpadden KK, Garcia JA, van den Berg CAT, Raaijmakers CPJ, Kerkmeijer L, Doornaert P, Blinde S, Frank SJ, Fuller CD.

Clin Transl Radiat Oncol. 2018 Aug 24;13:19-23. doi: 10.1016/j.ctro.2018.08.003. eCollection 2018 Nov.

8.

Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.

Ng SP, Bahig H, Wang J, Cardenas CE, Lucci A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, Ding Y, Ikner S, Dinh V, Elgohari BA, Johnson JM, Skinner HD, Gunn GB, Garden AS, Phan J, Rosenthal DI, Morrison WH, Frank SJ, Hutcheson KA, Mohamed ASR, Lai SY, Ferrarotto R, MacManus MP, Fuller CD.

BMC Cancer. 2018 Sep 19;18(1):903. doi: 10.1186/s12885-018-4808-5.

9.

Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy.

Ng SP, Koay EJ.

Ann Pancreat Cancer. 2018 Aug;1. pii: 22. doi: 10.21037/apc.2018.07.03. Epub 2018 Aug 13.

10.

A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter?

Ng SP, Dyer BA, Kalpathy-Cramer J, Mohamed ASR, Awan MJ, Gunn GB, Phan J, Zafereo M, Debnam JM, Lewis CM, Colen RR, Kupferman ME, Guha-Thakurta N, Canahuate G, Marai GE, Vock D, Hamilton B, Holland J, Cardenas CE, Lai S, Rosenthal D, Fuller CD.

Clin Transl Radiat Oncol. 2018 Aug 2;12:40-46. doi: 10.1016/j.ctro.2018.07.006. eCollection 2018 Aug.

11.

Outcome of patients with early-stage follicular lymphoma staged with 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy alone.

Ng SP, Khor R, Bressel M, MacManus M, Seymour JF, Hicks RJ, Wirth A.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):80-86. doi: 10.1007/s00259-018-4112-2. Epub 2018 Aug 7.

PMID:
30083824
12.

Significance of Negative Posttreatment 18-FDG PET/CT Imaging in Patients With p16/HPV-Positive Oropharyngeal Cancer.

Ng SP, Johnson JM, Gunn GB, Rosenthal DI, Skinner HD, Phan J, Frank SJ, Morrison W, Sturgis EM, Mott FE, Williams MD, Fuller CD, Garden AS.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1029-1035. doi: 10.1016/j.ijrobp.2018.06.031. Epub 2018 Jun 28.

PMID:
29960060
13.

Follow up results of a prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.

Ng SP, Tan J, Osbourne G, Williams L, Bressel MAB, Hicks RJ, Lau EWF, Chu J, Ngan SYK, Leong T.

Clin Transl Radiat Oncol. 2017 Mar 7;2:76-82. doi: 10.1016/j.ctro.2017.01.008. eCollection 2017 Feb.

14.

Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.

Kamal M, Ng SP, Eraj SA, Rock CD, Pham B, Messer JA, Garden AS, Morrison WH, Phan J, Frank SJ, El-Naggar AK, Johnson JM, Ginsberg LE, Ferrarotto R, Lewin JS, Hutcheson KA, Cardenas CE, Zafereo ME, Lai SY, Hessel AC, Weber RS, Gunn GB, Fuller CD, Mohamed ASR, Rosenthal DI.

Oral Oncol. 2018 Apr;79:1-8. doi: 10.1016/j.oraloncology.2018.01.025. Epub 2018 Feb 10.

15.

Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer.

Ng SP, Herman JM.

Cancers (Basel). 2018 Mar 16;10(3). pii: E75. doi: 10.3390/cancers10030075. Review.

16.

Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.

Kamal M, Mohamed ASR, Fuller CD, Sturgis EM, Johnson FM, Morrison WH, Gunn GB, Hutcheson KA, Phan J, Volpe S, Ng SP, Ferrarotto R, Frank SJ, Skinner HD, Rosenthal DI, Garden AS.

Cancer. 2018 Apr 1;124(7):1415-1427. doi: 10.1002/cncr.31235. Epub 2018 Jan 16.

17.

A Rare Case of Unresectable Adenoid Cystic Carcinoma of the Nasopharynx Treated with Intensity Modulated Proton Therapy.

Phan J, Ng SP, Pollard C III, Phan J.

Cureus. 2017 Sep 15;9(9):e1688. doi: 10.7759/cureus.1688.

18.

Combination Intensity Modulated Proton Therapy and Passive Scatter Boost for Rapidly Progressing Nasal Cavity Squamous Cell Carcinoma.

Ng SP, Ludmir EB, Oyervides MA, Wu RY, Frank S, Gunn GB.

Cureus. 2017 Sep 14;9(9):e1685. doi: 10.7759/cureus.1685.

19.

SBRT for Unresectable Pancreatic Cancer Can Improve Local Control With Minimal Toxicity.

Ng SP, Herman JM.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):298-299. doi: 10.1016/j.ijrobp.2017.05.034. No abstract available.

PMID:
28871974
20.

Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis.

Pollard C 3rd, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J.

Head Neck. 2017 Oct;39(10):2079-2087. doi: 10.1002/hed.24872. Epub 2017 Jul 25.

PMID:
28741749

Supplemental Content

Loading ...
Support Center